We sought to investigate the procedural and hemodynamic outcome after valve-in-valve transcatheter aortic valve replacement (VinV-TAVR) for different surgi
We present three cases of valve-in-valve (VIV) restenosis following TAVR with the balloon expandable transcatheter heart valves, presumably due to valve thrombosis that improved with anticoagulation. 漏 2016 Wiley Periodicals, Inc.doi:10.1002/ccd.26522Goleski, Patrick J....
Transcatheter Aortic Valve Replacement (TAVR)-Pilot Trial No drug interventions treatment Not Available withdrawn NCT05217888 The Sentinel Registry No drug interventions Not Available Not Available recruiting NCT06697249 Feasibility of Valve-in-Root Transcatheter Aortic Valve Implantation in 363 Patients Aft...
In the Valve-in-Valve International Data registry, severe preexisting mismatch between the patient and the failed surgical bioprosthesis was independently and strongly associated with increased risk for mortality after ViV-TAVR (33). Likewise, severe patient-prosthesis mismatch predicted adverse outcomes ...
Learn more about the transcatheter heart valve replacement (TAVR) procedure for your symptomatic severe aortic stenosis (SAS) patients.
In this global collaboration, women and men had similar rates of 30-day mortality and stroke. However, women had higher rates of procedural life-threatening or major bleeding after TAVR. Between 2007 and 2018, mortality rates decreased to a greater extent in men than in women. Central Illustrat...
Learn more about the transcatheter heart valve replacement (TAVR) procedure for your symptomatic severe aortic stenosis (SAS) patients.
Aortic Regurgitation (AR) produces the entrance of an abnormal amount of blood in the left ventricle. This disease is responsible for high morbidity and mo
At our institution an increase in valve failure rates of biological full root replacements has been observed. When the root can be preserved, a valve-in-root implantation is pursued. In contrast to TAVI, open surgery enables inspection of the valve and root in addition to excision of the leaf...
Transcatheter valve-in-valve replacement (TMViVR) is an alternative option for patients with bioprosthetic valve failure (BVF) who are at high surgical risk. Although infective endocarditis (IE) after transcatheter mitral valve-in-valve replacement is un